Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer.

Overview of attention for article published in Journal of Clinical Oncology, April 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 17 news outlets
blogs: 1 blog

twitter: 80 X users

Readers on

mendeley: 123 Mendeley

So far, Altmetric has seen 111 X posts from 80 X users, with an upper bound of 432,279 followers.

RT @MattGalsky: Switch maintenance pembro was "positive" - met primary endpoint of the study. We can only really answer the question that w…

Switch maintenance pembro was "positive" - met primary endpoint of the study. We can only really answer the question that we asked. https://t.co/rYnL6jwahr @achoud72 @PGrivasMDPhD

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 107 additional X posts.